Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul-Aug;76(4):365-367.
doi: 10.1016/j.therap.2021.03.005. Epub 2021 Apr 2.

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy

Thomas Soeiro  1 , Francesco Salvo  2 , Antoine Pariente  2 , Aurélie Grandvuillemin  3 , Annie-Pierre Jonville-Béra  4 , Joëlle Micallef  5
Affiliations

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy

Thomas Soeiro et al. Therapie. 2021 Jul-Aug.
No abstract available

Keywords: Bell's palsy; COVID-19 vaccines; Pharmacovigilance; Phase 3 clinical trials; Type I interferons.

PubMed Disclaimer

References

    1. FDA . 2021. Vaccines and related biological products advisory committee December 10, 2020 meeting announcement. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vacc.... [Accessed March 29, 2021]
    1. FDA . 2021. Vaccines and related biological products advisory committee December 17, 2020 meeting announcement. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vacc.... [Accessed March 29, 2021]
    1. De Beuckelaer A., Grooten J., De Koker S. Type I interferons modulate CD8 + T cell immunity to mRNA vaccines. Trends Mol Med. 2017;23:216–226. - PubMed
    1. Kamphuis E., Junt T., Waibler Z., Forster R., Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006;108:3253–3261. - PubMed
    1. Greco A., Gallo A., Fusconi M., Marinelli C., Macri G.F., de Vincentiis M. Bell's palsy and autoimmunity. Autoimmun Rev. 2012;12:323–328. - PubMed